Six major randomized control trials, ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, and REWIND have investigated cardiovascular outcomes in patients treated with injectable GLP1 agonists (5358)
Available plans or devices may vary by provider and location
GPLC combines a low dietary dose of PLC with the amino acid glycine, which itself has beneficial effects on heart health
PlexusDx offers multiple GLP-1 options including oral semaglutide, compounded tirzepatide injection, oral tirzepatide, and the GLP-Squared dual compound
While berberine is a powerful supplement with real metabolic benefits, it is not a direct substitute for a GLP-1 agonist
This personalized approach ensures your procedure plan addresses your specific concerns while setting realistic expectations for outcomes